feed,title,long_url,short_url
🔐MarketWatch,Protagonist's stock falls 27% after updating investors about experimental blood disorder drug,http://www.marketwatch.com/news/story/protagonists-stock-falls-27-after/story.aspx?guid=%7B365DF4DA%2D36C9%2D4495%2D92BF%2DD3B37C6D5820%7D&siteid=rss,https://on.mktw.net/3JInZgQ
